1. Robinson R. Cost-utility analysis. BMJ. 1993;307(6908):859-862. https://doi.org/10.1136/bmj.307.6908.859.
2. Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11(4):341-353. https://doi.org/10.1002/hec.673.
3. Pullenayegum EM, Sunderland KM, Johnson JA, Xie F. Handling regional variation in health state preferences within a country: a methodological framework. Med Decis Making. 2017;37(3):252-261. https://doi.org/10.1177/0272989X16651885.
4. Devlin NJ, Shah KK, Feng Y, Mulhern B, Hout BV. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018;27(1):7-22.
https://doi.org/10.1002/hec.3564.
5. Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ. Valuations of EQ-5D health states: are the United States and United Kingdom different. Med Care. 2005;43(3):221-228.
https://www.jstor.org/stable/3768220.
6. Lamers LM, McDonnell J, Stalmeier PFM, Krabbe PFM, Busschbach JJV. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121-1132. https://doi.org/10.1002/hec.1124.
7. National Bureau of Statistics. National Bureau of Statistics of the People's Republic of China [in Chinese]. http://data.stats.gov.cn/easyquery.htm?cn=C01. Acceesd 1 July 2021.
8. National Bureau of Statistics. Statistical bulletin on national economic and social development in 2020 [in Chinese]. http://www.stats.gov.cn/tjsj/zxfb/202102/t20210227_1814154.html. Acceesd 1 July 2021.
9. National Bureau of Statistics. The 2010 population census of the People’s Republic of China [in Chinese]. http://www.stats.gov.cn/tjsj/pcsj/rkpc/6rp/indexch.htm. Acceesd 1 July 2021.
10. National Bureau of Statistics. China Statistic Yearbook 2020 [in Chinese]. http://www.stats.gov.cn/tjsj/ndsj/2020/indexch.htm. Acceesd 1 July 2021.
11. National Health Commission of the People's Republic of China. China Health Statistic Yearbook 2020 [in Chinese]. Beijing: Peking Union Medical Clooege Press; 2021.
12. Liu GG, Hu SL, Wu JH, Wu J, Dong ZH, Li HC, et al. China Guidelines for Pharmacoeconomic Evaluations 2020 (Chinese-English Version). Beijing: China Market Press; 2020.
13. Luo N, Liu GG, Li MH, Guan HJ, Jin XJ, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20(4):662-669. https://doi.org/10.1016/j.jval.2016.11.016.
14. Liu GG, Wu HY, Li MH, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value health. 2014;17(5):597-604. https://doi.org/10.1016/j.jval.2014.05.007.
15. Zhuo L, Xu L, Ye JT, Sun S, Zhang YG, Burstrom K, et al. Time trade-off value set for EQ-5D-3L based on a nationally representative Chinese population survey. Value Health. 2018;21(11):1330-1337. https://doi.org/10.1016/j.jval.2018.04.1370.
16. Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics. 2018;36(6):675-697. https://doi.org/10.1007/s40273-018-0623-8.
17. You RX, Liu JY, Yang ZH, Pan CW, Ma QH, Luo N. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in an elderly Chinese population. Health Qual Life Outcomes. ;2020;18:97. https://doi.org/10.1186/s12955-020-01324-0.
18. Liang ZR, Zhang TT, Lin TF, Liu LS, Wang BY, Fu AZ, et al. Health-related quality of life among rural men and women with hypertension: assessment by the EQ-5D-5L in Jiangsu, China. Qual Life Res. 2019;28(8):2069-2080. https://doi.org/10.1007/s11136-019-02139-3.
19. Yang F, Jiang S, He XN, Li HC, Wu HY, Zhang TT, et al. Do rural residents in China understand EQ-5D-5L as intended? Evidence from a qualitative study. PharmacoEconomics. 2021;5(1):101-109. https://doi.org/10.1007/s41669-020-00212-z.
20. Kind P. A revised protocol for the valuation of health states defined by the EQ-5D-3L classification system: learning the lessons from the MVH study. Centre for Health Economics: University of York, 2009.
21. Furlong W, Feeny D, Torrance G, Barr R, Horsman J. Guide to Design and Development Health-State Utility Instrumentation. McMaster University Centre for Health Economics and Policy Analysis, CHEPA Working Paper, 1990. Available from: http://ideas.repec.org/p/hpa/wpaper/199009.html. Acceesd 1 July 2021.
22. Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health. 2009;12(8):1187-1193. https://doi.org/10.1111/j.1524-4733.2009.00579.x.
23. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095-1108. https://doi.org/10.1097/00005650-199711000-00002.